Effect of Subcutaneous Spesolimab on the Prevention of Generalized Pustular Psoriasis Flares Over 48 weeks: Subgroup Analyses from the Effisayil 2 Trial . J of Skin [Internet]. 2023 Nov. 13 [cited 2025 Jul. 3];7(6):s245. Available from: https://skin.dermsquared.com/skin/article/view/2431